312 related articles for article (PubMed ID: 36555449)
21. Clinical and immunological aspects of anti-peptidylarginine deiminase type 4 (anti-PAD4) autoantibodies in rheumatoid arthritis.
Reyes-Castillo Z; Muñoz-Valle JF; Llamas-Covarrubias MA
Autoimmun Rev; 2018 Feb; 17(2):94-102. PubMed ID: 29196243
[TBL] [Abstract][Full Text] [Related]
22. Post-translational modifications such as citrullination are excellent targets for cancer therapy.
Brentville VA; Vankemmelbeke M; Metheringham RL; Durrant LG
Semin Immunol; 2020 Feb; 47():101393. PubMed ID: 31932199
[TBL] [Abstract][Full Text] [Related]
23. An overview of autoantibodies in rheumatoid arthritis.
van Delft MAM; Huizinga TWJ
J Autoimmun; 2020 Jun; 110():102392. PubMed ID: 31911013
[TBL] [Abstract][Full Text] [Related]
24. Auto-antibodies to post-translationally modified proteins in osteoarthritis.
Xie X; van Delft MAM; Shuweihdi F; Kingsbury SR; Trouw LA; Doody GM; Conaghan PG; Ponchel F
Osteoarthritis Cartilage; 2021 Jun; 29(6):924-933. PubMed ID: 33757859
[TBL] [Abstract][Full Text] [Related]
25. Pitfalls in the detection of citrullination and carbamylation.
Verheul MK; van Veelen PA; van Delft MAM; de Ru A; Janssen GMC; Rispens T; Toes REM; Trouw LA
Autoimmun Rev; 2018 Feb; 17(2):136-141. PubMed ID: 29203292
[TBL] [Abstract][Full Text] [Related]
26. Autoantibodies to posttranslational modifications in rheumatoid arthritis.
Burska AN; Hunt L; Boissinot M; Strollo R; Ryan BJ; Vital E; Nissim A; Winyard PG; Emery P; Ponchel F
Mediators Inflamm; 2014; 2014():492873. PubMed ID: 24782594
[TBL] [Abstract][Full Text] [Related]
27. Clinical and pathophysiologic relevance of autoantibodies in rheumatoid arthritis.
de Brito Rocha S; Baldo DC; Andrade LEC
Adv Rheumatol; 2019 Jan; 59(1):2. PubMed ID: 30657101
[TBL] [Abstract][Full Text] [Related]
28. Crosstalk between B cells and neutrophils in rheumatoid arthritis.
Karmakar U; Vermeren S
Immunology; 2021 Dec; 164(4):689-700. PubMed ID: 34478165
[TBL] [Abstract][Full Text] [Related]
29. Autoantibodies targeting malondialdehyde-modifications in rheumatoid arthritis regulate osteoclasts via inducing glycolysis and lipid biosynthesis.
Sakuraba K; Krishnamurthy A; Sun J; Zheng X; Xu C; Peng B; Engström M; Jakobsson PJ; Wermeling F; Catrina S; Grönwall C; Catrina AI; Réthi B
J Autoimmun; 2022 Dec; 133():102903. PubMed ID: 36108504
[TBL] [Abstract][Full Text] [Related]
30. The use of citrullinated peptides for the diagnosis and prognosis of rheumatoid arthritis.
Haro I; Gómara MJ
Curr Top Med Chem; 2014; 14(23):2729-33. PubMed ID: 25515746
[TBL] [Abstract][Full Text] [Related]
31. Microbial pathways to subvert host immunity generate citrullinated neoantigens targeted in rheumatoid arthritis.
Gómez-Bañuelos E; Konig MF; Andrade F
Curr Opin Struct Biol; 2022 Aug; 75():102423. PubMed ID: 35834948
[TBL] [Abstract][Full Text] [Related]
32. Autoantibodies to citrullinated proteins in rheumatoid arthritis: clinical performance and biochemical aspects of an RA-specific marker.
Nijenhuis S; Zendman AJ; Vossenaar ER; Pruijn GJ; vanVenrooij WJ
Clin Chim Acta; 2004 Dec; 350(1-2):17-34. PubMed ID: 15530456
[TBL] [Abstract][Full Text] [Related]
33. Autoantibodies in inflammatory arthritis.
Conigliaro P; Chimenti MS; Triggianese P; Sunzini F; Novelli L; Perricone C; Perricone R
Autoimmun Rev; 2016 Jul; 15(7):673-83. PubMed ID: 26970491
[TBL] [Abstract][Full Text] [Related]
34. Citrullinated proteins in rheumatoid arthritis.
Yamada R; Suzuki A; Chang X; Yamamoto K
Front Biosci; 2005 Jan; 10():54-64. PubMed ID: 15574347
[TBL] [Abstract][Full Text] [Related]
35. Post-translational modifications in rheumatoid arthritis and atherosclerosis: Focus on citrullination and carbamylation.
Spinelli FR; Pecani A; Conti F; Mancini R; Alessandri C; Valesini G
J Int Med Res; 2016 Sep; 44(1 suppl):81-84. PubMed ID: 27683146
[TBL] [Abstract][Full Text] [Related]
36. Citrullinated peptide and its relevance to rheumatoid arthritis: an update.
Luban S; Li ZG
Int J Rheum Dis; 2010 Oct; 13(4):284-7. PubMed ID: 21199462
[TBL] [Abstract][Full Text] [Related]
37. Insights into the study and origin of the citrullinome in rheumatoid arthritis.
Fert-Bober J; Darrah E; Andrade F
Immunol Rev; 2020 Mar; 294(1):133-147. PubMed ID: 31876028
[TBL] [Abstract][Full Text] [Related]
38. Anti-citrulline antibodies in the diagnosis and prognosis of rheumatoid arthritis: evolving concepts.
Raptopoulou A; Sidiropoulos P; Katsouraki M; Boumpas DT
Crit Rev Clin Lab Sci; 2007; 44(4):339-63. PubMed ID: 17558653
[TBL] [Abstract][Full Text] [Related]
39. Update on autoantibodies to modified proteins.
Toes RE; Huizinga TJ
Curr Opin Rheumatol; 2015 May; 27(3):262-7. PubMed ID: 25760280
[TBL] [Abstract][Full Text] [Related]
40. Citrullination and carbamylation in the pathophysiology of rheumatoid arthritis.
Pruijn GJ
Front Immunol; 2015; 6():192. PubMed ID: 25964785
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
